TITLE

EZH2 regulates cancer cell migration through repressing TIMP-3 in non-small cell lung cancer

AUTHOR(S)
Xu, Chunhua; Hou, Zhibo; Zhan, Ping; Zhao, Wei; Chang, Cunjie; Zou, Jue; Hu, Huidi; Zhang, Yuanqin; Yao, Xin; Yu, Like; Yan, Jun
PUB. DATE
December 2013
SOURCE
Medical Oncology;Dec2013, Vol. 30 Issue 4, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
92576989

 

Related Articles

  • The Role of EZH2 in the Regulation of the Activity of Matrix Metalloproteinases in Prostate Cancer Cells. Yong Jae Shin; Jeong-Ho Kim // PLoS ONE;Jan2012, Vol. 7 Issue 1, p1 

    Degradation of the extracellular matrix (ECM), a critical step in cancer metastasis, is determined by the balance between MMPs (matrix metalloproteinases) and their inhibitors TIMPs (tissue inhibitors of metalloproteinases). In cancer cells, this balance is shifted towards MMPs, promoting ECM...

  • The Role of EZH2 in the Regulation of the Activity of Matrix Metalloproteinases in Prostate Cancer Cells. Yong Jae Shin; Jeong-Ho Kim // PLoS ONE;Jan2012, Vol. 7 Issue 1, p1 

    Degradation of the extracellular matrix (ECM), a critical step in cancer metastasis, is determined by the balance between MMPs (matrix metalloproteinases) and their inhibitors TIMPs (tissue inhibitors of metalloproteinases). In cancer cells, this balance is shifted towards MMPs, promoting ECM...

  • EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers. Au, Sandy Leung-Kuen; Wong, Carmen Chak-Lui; Lee, Joyce Man-Fong; Wong, Chun-Ming; Ng, Irene Oi-Lin // PLoS ONE;Jun2013, Vol. 8 Issue 6, p1 

    Enhancer of zeste homolog 2 (EZH2), the histone methyltransferase of the Polycomb Repressive complex 2 catalyzing histone H3 lysine 27 tri-methylation (H3K27me3), is frequently up-regulated in human cancers. In this study, we identified the tumor suppressor Deleted in liver cancer 1 (DLC1) as a...

  • EZH2 Promotes Malignant Behaviors via Cell Cycle Dysregulation and Its mRNA Level Associates with Prognosis of Patient with Non-Small Cell Lung Cancer. Wei Cao; Rachel de Oliveira Ribeiro; Diane Liu; Pierre Saintigny; Ronghui Xia; Yuwen Xue; Ruxian Lin; Li Mao; Hening Ren // PLoS ONE;Dec2012, Vol. 7 Issue 12, p1 

    Background: Epigenetic silencing is a common mechanism to inactivate tumor suppressor genes during carcinogenesis. Enhancer of Zeste 2 (EZH2) is the histone methyltransferase subunit in polycomb repressive complex 2 which mediates transcriptional repression through histone methylation. EZH2...

  • An endogenous inhibitor of angiogenesis inversely correlates with side population phenotype and function in human lung cancer cells. Han, H; Bourboulia, D; Jensen-Taubman, S; Isaac, B; Wei, B; Stetler-Stevenson, W G // Oncogene;2/27/2014, Vol. 33 Issue 9, p1198 

    The side population (SP) in human lung cancer cell lines and tumors is enriched with cancer stem cells. An endogenous inhibitor of angiogenesis known as tissue inhibitor of matrix metalloproteinase-2 (TIMP-2), characterized for its ability to inhibit matrix metalloproteinases (MMPs), has been...

  • EZH2 inhibition decreases p38 signaling and suppresses breast cancer motility and metastasis. Moore, Heather; Gonzalez, Maria; Toy, Kathy; Cimino-Mathews, Ashley; Argani, Pedram; Kleer, Celina // Breast Cancer Research & Treatment;Apr2013, Vol. 138 Issue 3, p741 

    EZH2 is a Polycomb group protein that exerts oncogenic functions in breast cancer, where its overexpression is associated with metastatic disease. While it reportedly acts a transcriptional repressor through trimethylation of histone H3 at lysine 27, EZH2 may exhibit context-dependent activating...

  • The polycomb group protein EZH2 is involved in progression of prostate cancer. Varambally, Sooryanarayana; Dhanasekaran, Saravana M.; Zhou, Ming; Barrette, Terrence R.; Kumar-Sinha, Chandan; Sanda, Martin G.; Ghosh, Debashis; Pienta, Kenneth J.; Sewalt, Richard G. A. B.; Otte, Arie P.; Rubin, Mark A.; Chinnaiyan, Arul M. // Nature;10/10/2002, Vol. 419 Issue 6907, p624 

    Prostate cancer is a leading cause of cancer-related death in males and is second only to lung cancer. Although effective surgical and radiation treatments exist for clinically localized prostate cancer, metastatic prostate cancer remains essentially incurable. Here we show, through gene...

  • Polycomb protein EZH2 regulates cancer cell fate decision in response to DNA damage. Wu, Z; Lee, S T; Qiao, Y; Li, Z; Lee, P L; Lee, Y J; Jiang, X; Tan, J; Aau, M; Lim, C Z H; Yu, Q // Cell Death & Differentiation;Nov2011, Vol. 18 Issue 11, p1771 

    Polycomb protein histone methyltransferase enhancer of Zeste homologe 2 (EZH2) is frequently overexpressed in human malignancy and is implicated in cancer cell proliferation and invasion. However, it is largely unknown whether EZH2 has a role in modulating DNA damage response. Here, we show that...

  • Suppression of lung adenocarcinoma through menin and polycomb gene-mediated repression of growth factor pleiotrophin. Gao, S.-B.; Feng, Z.-J.; Xu, B.; Wu, Y.; Yin, P.; Yang, Y.; Hua, X.; Jin, G.-H. // Oncogene;11/19/2009, Vol. 28 Issue 46, p4095 

    Menin upregulates transcription of cell-cycle inhibitors to suppress endocrine tumors, but it is poorly understood how menin suppresses non-endocrine tumors such as lung cancer. Here, we show that menin inhibits proliferation of human lung cancer cells and growth of lung cancer in mice. The...

  • CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells. Yongkun Wei; Ya-Huey Chen; Long-Yuan Li; Jingyu Lang; Su-Peng Yeh; Bin Shi; Cheng-Chieh Yang; Jer-Yen Yang; Chun-Yi Lin; Chien-Chen Lai; Mien-Chie Hung // Nature Cell Biology;Jan2011, Vol. 13 Issue 1, p87 

    Enhancer of zeste homologue 2 (EZH2) is the catalytic subunit of Polycomb repressive complex 2 (PRC2) and catalyses the trimethylation of histone H3 on Lys 27 (H3K27), which represses gene transcription. EZH2 enhances cancer-cell invasiveness and regulates stem cell differentiation. Here, we...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics